HIF-3 α Antibodies

Santa Cruz Biotechnology provides a broad selection of HIF-3α monoclonal antibodies for research in hypoxia and cellular response mechanisms. HIF-3 α Antibodies are available for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HIF-3α, or Hypoxia-Inducible Factor 3 Alpha, plays a central role in the cellular response to low oxygen levels, regulating gene expression involved in metabolism, angiogenesis, and cell survival. Understanding HIF-3α function is essential for exploring its implications in various diseases, including cancer and ischemic conditions. Research focused on HIF-3α continues to reveal new insights into cellular adaptation mechanisms under hypoxic conditions. Investigating HIF-3α signaling pathways helps researchers better understand how cells respond and adapt to oxygen deprivation. Current studies of HIF-3α are uncovering potential therapeutic targets for conditions involving oxygen deficiency. HIF-3α research supported by Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific understanding of hypoxia-related diseases and potential treatments.